Tag Archives: pharmaceutical

Wealth Matters: Stock Focus

Shire plc We purchased Shire plc at circa £37 per share when rumours broke that Japanese drugmaker Takeda Pharmaceutical Co was interested in taking over the company. On 25th April 2018, Takeda and Shire directors finally agreed on a deal that they were both happy to recommend to Shareholders. The purchase price is in flux, […]